Drug info - γ-Hydroxybutyrate (GHB) in Humans

[Bajeda]

A new entry has been added to Drugs Archive

Description: Despite γ-hydroxybutyrate (GHB) therapeutic uses and the increasing concern about its toxicity, few studies have addressed GHB dose-related effects under controlled administration and their relationship with its pharmacokinetics. The study design was double-blind, randomized, crossover, and controlled. As a pilot pharmacology phase I study, increasing doses of GHB were given. Single oral sodium GHB doses (40, 50, 60, and 72 mg/kg) were administered to eight volunteers. Plasma and urine were analyzed for GHB by gas chromatography–mass spectrometry. Physiological effects, psychomotor performance, and subjective effects were examined simultaneously. GHB produced dose-related changes in subjective effects as measured by questionnaires and VAS.

To check it out, rate it or add comments, visit γ-Hydroxybutyrate (GHB) in Humans
The comments you make there will appear in the posts below.